Peripheral Arterial Disease(PAD)NCT06631378
Transverse Versus Longitudinal Groin Incision in Vascular Surgery
A study testing Transverse groin incision and Longitudinal incision in people with Peripheral Arterial Disease(PAD) and Aneurysmal Disease, run by Kolding Sygehus at 1 site in Denmark.
Trial summary
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery. The main questions it aims to answer are: Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Peripheral Arterial Disease(PAD), Aneurysmal Disease
- What is being tested?
- Transverse groin incision and Longitudinal incision
- Type of treatment
- Pill or oral medicine, Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 232 participants
- Where
- 1 siteDenmark
- Study dates
- 1 Mar 2025to 1 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients undergoing vascular reconstruction with a groin incision
Who cannot join
- Patients previously operated with a groin incision.
- Patients undergoing operation due to trauma, bleeding, or pseudoaneurysm.
- Patients operated within the first 24 hours of admission.
- If it prior to the operation is deemed necessary with a muscleplasty.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Denmark1 site, 1 recruiting
- Recruiting
Department of Vascular Surgery - Lillebaelt Hospital
Kolding, 6000
Christina P Madsen, MD, 0045 76360788, christina.pilgaard.madsen@rsyd.dk
Trine M M Jørgensen, MD PhD
About this study
Official title: The Incidence of Surgical Site Complications in Transverse Versus Longitudinal Groin Incision in Vascular Surgery: A Randomized Clinical Trial
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery.
The main questions it aims to answer are:
Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate.
Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.
- Being tested
- Transverse groin incision, Longitudinal incision
- Keywords
- groin wound complications, surgical site complications, surgical site complication, vascular surgery, incision type, incision
- Medical subject headings
- Peripheral Arterial Disease, Surgical Wound
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transverse groin incisionProcedure or surgery
The transverse incision is made parallel to the inguinal ligament either superiorly or inferiorly to the skin crease directly over the femoral artery. The subcutaneous tissue is dissected in the transverse direction till Scarpaes fascia after which the dissection is performed in the longitudinal direction along the line of the vessels. The lymphatic vessels are spared as much as possible. Any damaged lymph vessels are closed with surgical clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. In case of difficulty with proper access to the femoral arteries, the incision can be extended either medially, laterally, or vertically.
Longitudinal incisionProcedure or surgery
The longitudinal incision is made directly over the femoral artery from the inguinal ligament. The subcutaneous tissue is dissected along the line of the vessel sparing the lymphatic vessels as much as possible. Any damaged lymph vessels are closed with clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage.
| Study group | Role | What they receive |
|---|---|---|
| Transverse groin incision | Experimental | Not described Receives: Procedure: Transverse groin incision |
| Longitudinal groin incision | Active comparator | Not described Receives: Procedure: Longitudinal incision |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of surgical site complications
The surgical site complications are defined as follows:
- Surgical site infection according to the Szilagy classification:
- Dehiscence with separation of the wound edges and exposure of the underlying tissue.
- Lymhocele defined as the presence of localized swelling in the groin and verified on ultrasound as an anechoic fluid collection.
- Hematoma defined as the presence of localized swelling in the groin with discoloration and verified on ultrasound as an echoic fluid collection.
Measured: 35 days after the operation
Secondary outcomes (5)
Reoperation
Reoperation in the groin due to surgical site complications Reoperation due to the reconstruction Minor or major amputation
Measured: 35 days after the operation
Readmission
Is the patient readmitted due to either surgical site complications or for other reasons
Measured: 35 days
• Length of stay
The duration of the hospital stay after the operation.
Measured: 35 days
Mortality
Death and the cause of death.
Measured: 35 days
Healing of the groin
Evaluation of the groin to access if it has healed irrespective of the development of surgical site complications.
Measured: 35 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2024
- Study start1 Mar 2025
- Primary completion1 Jun 2027 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Peripheral Arterial Disease(PAD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The trial is a single center superiority randomized clinical trial with two parallel groups with 1:1 randomization to either transverse or longitudinal incision in the groin in vascular surgery with arterial reconstruction.
- Masking
- None (open label)
- Enrolment
- 232 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kolding Sygehus
- Sponsor type
- University, hospital or other
- Collaborators
- Region of Southern Denmark, University of Southern Denmark
- Responsible party
- Principal investigator, Christina Pilgaard Madsen, Kolding Sygehus
- Investigators
- Kim Trine Maria Mejnert Jørgensen, MD, PhD, Study director, Department of vascular surgery, Kolding Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06631378
- Sponsor's protocol ID
- KoldingSygehusKarkir
- Status last verified
- Mar 2025
- First submitted
- 27 Sep 2024
- Last updated
- 27 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Incidence of Surgical Site Complications in Transverse Versus Longitudinal Groin Incision in Vascular Surgery: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT06631378
- Acronym / sponsor ID
- KoldingSygehusKarkir
- Keywords
- groin wound complications, surgical site complications, surgical site complication, vascular surgery, incision type, incision
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 232 participants (estimated)
- Lead sponsor
- Kolding SygehusUniversity, hospital or other
- Collaborators
- Region of Southern Denmark, University of Southern Denmark
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 1 Jun 2027 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 8 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery.
The main questions it aims to answer are:
Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate.
Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The trial is a single center superiority randomized clinical trial with two parallel groups with 1:1 randomization to either transverse or longitudinal incision in the groin in vascular surgery with arterial reconstruction.
| Arm | Type | Receives |
|---|---|---|
| Transverse groin incision | Experimental | Procedure: Transverse groin incision |
| Longitudinal groin incision | Active comparator | Procedure: Longitudinal incision |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Patients undergoing vascular reconstruction with a groin incision
Key exclusion criteria (4 listed)
- Patients previously operated with a groin incision.
- Patients undergoing operation due to trauma, bleeding, or pseudoaneurysm.
- Patients operated within the first 24 hours of admission.
- If it prior to the operation is deemed necessary with a muscleplasty.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transverse groin incisionThe transverse incision is made parallel to the inguinal ligament either superiorly or inferiorly to the skin crease directly over the femoral artery. The subcutaneous tissue is dissected in the transverse direction till Scarpaes fascia after which the dissection is performed in the longitudinal direction along the line of the vessels. The lymphatic vessels are spared as much as possible. Any damaged lymph vessels are closed with surgical clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. In case of difficulty with proper access to the femoral arteries, the incision can be extended either medially, laterally, or vertically. | Procedure or surgery | Transverse groin incision |
| Longitudinal incisionThe longitudinal incision is made directly over the femoral artery from the inguinal ligament. The subcutaneous tissue is dissected along the line of the vessel sparing the lymphatic vessels as much as possible. Any damaged lymph vessels are closed with clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. | Procedure or surgery | Longitudinal groin incision |
Primary outcome
Incidence of surgical site complications
Time frame: 35 days after the operation
The surgical site complications are defined as follows: * Surgical site infection according to the Szilagy classification: * Dehiscence with separation of the wound edges and exposure of the underlying tissue. * Lymhocele defined as the presence of localized swelling in the groin and verified on ultrasound as an anechoic fluid collection. * Hematoma defined as the presence of localized swelling in the groin with discoloration and verified on ultrasound as an echoic fluid collection.
5 secondary outcomes
Reoperation
Time frame: 35 days after the operation
Readmission
Time frame: 35 days
• Length of stay
Time frame: 35 days
Mortality
Time frame: 35 days
Healing of the groin
Time frame: 35 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Peripheral Arterial Disease(PAD)
Active, not recruiting
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
Peripheral Artery Disease
RecruitingPhase 3
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Peripheral Artery Disease (PAD)
Recruiting
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
Not yet recruiting
Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study
Peripheral Artery Disease (PAD), Intermittent Claudication
Enrolling by invitationEarly Phase 1
Truway Diagnostic Tools in Primary Care
Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kim Trine Maria Mejnert Jørgensen, MD, PhD study director
Department of vascular surgery, Kolding Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transverse groin incision and Longitudinal incision in people with Peripheral Arterial Disease(PAD) and Aneurysmal Disease, run by Kolding Sygehus at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Christina P Madsen, Dr (+4576360788, christina.pilgaard.madsen@rsyd.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of surgical site complications (time frame: 35 days after the operation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2025.